arrow
L

Larry J. Copeland

 ohio state university
H指数:57
被引数:1.4万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Joint Gynecologic Oncology Group (GOG)-Foundation and European Network of Gynaecological Oncological Trial Groups (ENGOT) Clinical Trials Guidance for Operations with Industry Partners

妇科肿瘤学组(GOG)基金会与欧洲妇科肿瘤临床试验组网络(ENGOT)关于与行业伙伴合作手术的临床试验指南

2026-05-080
OAAI
Implementing non-invasive biospecimen collection in gynecologic oncology: Insights from a prospective gut microbiome feasibility study

在妇科肿瘤学中实施无创生物样本采集:来自前瞻性肠道微生物组可行性研究的见解

2026-05-010
OA
Evaluation of immunotherapy response in the radiated field in patients with recurrent endometrial and cervical cancer

放射野内免疫治疗反应在复发性子宫内膜癌和宫颈癌患者中的评估

2026-04-010
OAAI
The price of delay: Insurance-related treatment delays in patients with gynecologic cancer receiving immunotherapy

延迟的代价:接受免疫治疗的妇科癌症患者中与保险相关的治疗延迟

2025-08-290
PRE
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc’s Scholar Career Development Award and New Investigator Program

扩大致力于妇科肿瘤研究的临床试验研究者队伍:GOG Foundation, Inc.的学者职业发展奖和新研究者项目

2025-06-210
OAAI
A Plain Language Summary of Dostarlimab for primary advanced or recurrent endometrial cancer
2024-07-010
PRE
Changes in prospectively collected patient-reported outcomes among women with incident endometrial cancer
2024-01-241
OAAI
Patient-reported outcomes (PROs) in patients (pts) with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial
2023-10-012
PRE
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
2023-06-08294
OA
Postoperative venous thromboembolism risk stratification in patients with uterine cancer
2023-05-013
PRE
The Contemporary Presentation and Diagnosis of Endometrial Cancer Recurrence: When, Where, and How?
2023-02-010
PRE
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer
2023-01-012
PRE
Symptoms of Women With High-Risk Early-Stage Ovarian Cancer
2022-06-010
OA
Symptoms of Women With High-Risk Early-Stage Ovarian Cancer Reply
2022-06-010
PRE
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia

子宫内膜上皮内瘤变或复杂不典型增生子宫切除术时子宫内膜癌的术前预测因素

2020-01-0165
OAAI
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
2019-02-0135
OAAI
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
LANCET
IF88.5
2017-10-01454
OAAI
Ovarian Cancer, Version 1.2016
2016-09-01252
OAAI
A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer
2016-03-0117
PREAI